Kubota Pharmaceutical Holdings Co's total inventories for the quarter that ended in Mar. 2026 was 円5.34 Mil. Kubota Pharmaceutical Holdings Co's average total inventories from the quarter that ended in Dec. 2025 to the quarter that ended in Mar. 2026 was 円4.55 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Kubota Pharmaceutical Holdings Co's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was 円11.57.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Kubota Pharmaceutical Holdings Co's Days Inventory for the
three
months ended in Mar. 2026 was 273.33.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Kubota Pharmaceutical Holdings Co's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.33.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Kubota Pharmaceutical Holdings Co's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.97.
Kubota Pharmaceutical Holdings Co (TSE:4596) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Kubota Pharmaceutical Holdings Co's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Kubota Pharmaceutical Holdings Co's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Kubota Pharmaceutical Holdings Co Total Inventories Related Terms
Kubota Pharmaceutical Holdings Co Total Inventories Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kubota Pharmaceutical Holdings Co Total Inventories Chart
Kubota Pharmaceutical Holdings Co Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Kubota Pharmaceutical Holdings Co (TSE:4596) has a Total Inventories of 円5.34 Mil as of Mar. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Kubota Pharmaceutical Holdings Co and its competitors.
Is Kubota Pharmaceutical Holdings Co's Total Inventories too high?
Kubota Pharmaceutical Holdings Co's current Total Inventories is 円5.34 Mil. Overall, Kubota Pharmaceutical Holdings Co has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kubota Pharmaceutical Holdings Co's Total Inventories compare to VRTX and REGN?
Kubota Pharmaceutical Holdings Co's Total Inventories of 円5.34 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Biotechnology company?
A good Total Inventories depends on the Biotechnology industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Kubota Pharmaceutical Holdings Co and its competitors. Kubota Pharmaceutical Holdings Co's current Total Inventories is 円5.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kubota Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Kubota Pharmaceutical Holdings Co (TSE:4596) is currently considered Significantly Overvalued. The stock's GF Value™ is 円39.87, compared to a current price of 円56.00 — trading 40.5% above its estimated fair value. The current Total Inventories is 円5.34 Mil. Kubota Pharmaceutical Holdings Co's overall GF Score™ is 46/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Kubota Pharmaceutical Holdings Co (TSE:4596), the current Total Inventories is 円5.34 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kubota Pharmaceutical Holdings Co (TSE:4596) Overvalued in 2026?
Based on GuruFocus' analysis, Kubota Pharmaceutical Holdings Co stock appears to be overvalued.
The current stock price of 円56.00 is trading 40.5% above its estimated GF Value™ of 円39.87.
GuruFocus considers Kubota Pharmaceutical Holdings Co to be Significantly Overvalued.
Key valuation signals for TSE:4596:
Total Inventories: 円5.34 Mil
GF Value™: 円39.87 vs. price of 円56.00 (40.5% above fair value)
No single metric tells the full story. See the TSE:4596 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kubota Pharmaceutical Holdings Co Business Description
Kubota Pharmaceutical Holdings Co Ltd is a Japanese company providing portfolio of drugs and devices to preserve and restore millions of people. It identifies and develops therapeutics to treat the opthalmic disorder and operations incidental or related thereto. Its pipeline products include VCM-Emixustat HCI, Lanosterol and Optogenetics.
46GF Score
Get the complete analysis for TSE:4596
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4596 has been successfully added to your 
